Fibrodysplasia ossificans progressiva in Hong Kong-A case report series

被引：0

作者：

Chan, Joshua Chun Ki ^{[1
]}

Kuong, Evelyn Eugenie ^{[2
,3
]}

Chan, Joyce Pui Kwan ^{[2
,4
]}

Luk, Ho Ming ^{[5
]}

Fung, Jasmine Lee Fong ^{[6
]}

Tung, Joanna Yuet-ling ^{[2
,7
]}

Chung, Brian Hon Yin ^{[2
,6
]}

机构：

[1] Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China

[2] Hong Kong Childrens Hosp, Skeletal Dysplasia Joint Clin, Hong Kong, Peoples R China

[3] Duchess Kent Childrens Hosp, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China

[4] Hong Kong Childrens Hosp, Dept Radiol, Hong Kong, Peoples R China

[5] Hong Kong Childrens Hosp, Clin Genet Serv Unit, Hong Kong, Peoples R China

[6] Univ Hong Kong, LKS Fac Med, Sch Clin Med, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China

[7] Hong Kong Childrens Hosp, Dept Paediat & Adolescent Med, Hong Kong, Peoples R China

来源：

FRONTIERS IN PEDIATRICS | 2023年 / 11卷

关键词：

case report; fibrodysplasia ossificans progressiva; ACVR1; Hong Kong; FOP; PHENOTYPE; GENOTYPE;

D O I：

10.3389/fped.2023.1152731

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare condition. The diagnosis could be challenging due to its rarity and non-specific presenting symptoms. However, early diagnosis and appropriate management help in preserving patients' function and quality of life. Herein, we report the diagnostic journeys and clinical courses of 8 patients with FOP in Hong Kong and illustrate the challenges involved.

引用

页数：8

共 18 条

[1] Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases [J].

Baujat, Genevieve ;

Choquet, Remy ;

Bouee, Stephane ;

Jeanbat, Viviane ;

Courouve, Laurene ;

Ruel, Amelie ;

Michot, Caroline ;

Le Quan Sang, Kim-Hanh ;

Lapidus, David ;

Messiaen, Claude ;

Landais, Paul ;

Cormier-Daire, Valerie .

ORPHANET JOURNAL OF RARE DISEASES, 2017, 12

[2]

Census & Statistics Department HKSAR, 2021, POP CENS

[3]

CONNOR JM, 1982, J MED GENET, V19, P35, DOI 10.1136/jmg.19.1.35

[4] Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1R206H Mouse Model of Fibrodysplasia Ossificans Progressiva [J].

Convente, Michael R. ;

Chakkalakal, Salin A. ;

Yang, EnJun ;

Caron, Robert J. ;

Zhang, Deyu ;

Kambayashi, Taku ;

Kaplan, Frederick S. ;

Shore, Eileen M. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (02) :269-282

[5]

Dahir KM, 2021, J ENDOCR SOC, V5, pA251, DOI [10.1210/jendso/bvab048.512, 10.1210/jendso/bvab048.512, DOI 10.1210/JENDSO/BVAB048.512]

[6] Palovarotene: First Approval [J].

Hoy, Sheridan M. .

DRUGS, 2022, 82 (06) :711-716

[7] Fibrodysplasia Ossificans Progressiva: Clinical Course, Genetic Mutations and Genotype-Phenotype Correlation [J].

Huening, Irina ;

Gillessen-Kaesbach, Gabriele .

MOLECULAR SYNDROMOLOGY, 2014, 5 (05) :201-211

[8] Evolving Management of Fibrodysplasia Ossificans Progressiva [J].

Kannu, Peter ;

Levy, Charles E. .

JOURNAL OF PEDIATRICS, 2021, 232 :S9-S15

[9] A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP) [J].

Kaplan, Frederick S. ;

Al Mukaddam, Mona ;

Pignolo, Robert J. .

BONE, 2017, 101 :123-128

[10]

Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868

← 1 2 →